GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2009) 14, 775-788. doi:10.1111/j.1365-2443.2009.01309.x
© 2009 Blackwell Publishing or its licensors

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sang, M.
Right arrow Articles by Ozaki, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sang, M.
Right arrow Articles by Ozaki, T.

Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation

Meixiang Sang1,2, Kiyohiro Ando1, Rintaro Okoshi1, Nami Koida1, Yuanyuan Li1, Yuyan Zhu1, Osamu Shimozato1, Cuizhi Geng3, Baoen Shan2, Akira Nakagawara1 and Toshinori Ozaki1

1 Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan
2 The Research Center of the Fourth Hospital of Hebei Medical University, Hebei 050017, China
3 The First Surgery, The Fourth Hospital of Hebei Medical University, Hebei 050017, China

Plk3, one of Polo-like kinase family members, is involved in the regulation of cell cycle progression and DNA damage response. In this study, we found that Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation. During cisplatin (CDDP)-mediated apoptosis, Plk3 was transcriptionally induced, whereas its protein level was kept at basal level, suggesting that Plk3 might rapidly degrade in response to CDDP. Immunoprecipitation and in vitro pull-down experiments demonstrated that Plk3 interacts with p73. Luciferase reporter assays and RT-PCR experiments revealed that Plk3 inhibits p73-mediated transcriptional activity. Consistent with these results, pro-apoptotic activity of p73 was blocked by Plk3. Additionally, Plk3 decreased the stability of p73. Intriguingly, kinase-deficient Plk3 failed to inhibit p73 function, indicating that kinase activity of Plk3 is required for Plk3-mediated inhibition of p73. Indeed, in vitro kinase reaction showed that NH2-terminal portion of p73 is phosphorylated by Plk3. In accordance with these observations, knocking down of Plk3 increased the stability of p73 and promoted CDDP-mediated apoptosis in association with up-regulation of p73. Collectively, our present findings suggest that Plk3 plays an important role in the regulation of cell fate determination in response to DNA damage through the inhibition of p73.


Communicated by: Takeo Kishimoto

* Correspondence: akiranak{at}chiba-cc.jp or tozaki{at}chiba-cc.jp







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
Copyright © 2009 by Wiley-Blackwell Publishing.